RSS

GNBTQ Generex Biotechnology Corp.

Mod: rjs9787 Asst: docj
Last Post: 06/11/26
Followers: 122
Posts Today: 0
Views Today: 5858

GNBTQ Stock Quote & Tools

$0.0000 ▲ +0.0000 (+0.00%) As of Jan 25, 4:00 PM
Last0.0000
$ Chg0.0000
Open—
High—
Beta0.5408
Year High—
Market Cap—
P/B Ratio-0.54
EPS—
Avg Vol (30d)0
Volume—
% Chg+0.00%
Prev Close0.0000
Low—
VWAP0.00000
Year Low—
Total Shares118.45M
Shares Out118.45M
Float116.37M
Exchange
Healthcare Biotechnology & Life Sciences
Company Profile Buy Rating Time & Sales News Filings Financials

GNBTQ Stock Message Board Discussion

  1. Buildit

    ... and a lot of investment bankers and large investors...

  2. Buildit

    Well, BARDA is headquartered in DC. None of the other vaccine deals center on the US. So what

    (2)
  3. Victory

    Buildit I was able to get swab to transfer NGIO shares to my account only because it now shows

    (2)
  4. AlbertD

    Quarantine in a hotel in NYC? Did I miss something?

  5. hylander

    So, whats the work exactly?

  6. docj

    Looking at the Generex FB page it looks like someone who understands social media(twitter) has

    (1)
  7. docj

    "NYC bound, cant wait to see the horror in my old once great City, not looking forward to this

  8. Southbill

    Interesting day agreed. Relatively low volume. But they were still working it. I started sparring

    (4)
  9. skipper1072

    I'm impressed with the Wise Oz's knowledge. He gives unfiltered praise for GNBT - great work by Joe

  10. Paul Jackson

    Sorry...I meant to sent a private message...please feel free to delete my msg.

  11. Paul Jackson

    Hi, Thanks for the prayer! Your prayer must have worked...PPS closed up today. I will

  12. tc2000chartreader

    Gmin ah the days we were at $0.39 a share! Dreamy!

    (1)
  13. balleroni

    I sense a change in end of day trading since the CC ... I'm wondering if bad actors heard Joe's not

  14. hylander

    Agreed and someone tried to bring it down at the end as well. Have a great weekend as well!

  15. Buildit

    Interesting close. Doesnt seem to be a reason yet for a late couple of cents... but Ill take

    (2)
  16. Cody760

    Another week. Ho hum.

  17. hylander

    No major news week. Maybe next week we hear about the Peptides.

    (1)
  18. Beasley

    Kiromic down 6.67% KRBP on its IPO

  19. docj

    Reiterates the next Bintai deal (options) should close in about a week.

    (1)
  20. docj

    Money Info with The Great Wize Oz from 10/13. Takes a few minutes to get going.

    (2)
  21. hylander

    I actually prefer the 4.00 as it gives gnbt shareholders the bigger value overall in NGIO and GNBT

    (1)
  22. Buildit

    And you don't have to "assume" $4... that is my conclusion from reviewing the Naz listing

  23. Buildit

    Not being a professional at company valuation, I would guess anything signed will be used, and

    (1)
  24. hylander

    Ok then, let's 'assume' 4.00 then. Will they use the deal with BK as part of the valuation and

  25. Buildit

    Yeah, I've suspected that as well. The total shares may have gotten larger than absolutely

  26. Pokey123

    My take on the share count is that when Joe was forced to give up NGIO shares as part of the div he

  27. skipper1072

    For those who have never seen a bio-manufacturing plant check out this Hanmi video. NGIO will be

    (3)
  28. Buildit

    Yes, as I said, Joe had his reasons for the 400MM shares. However, he made that decision without a

  29. Cab408

    This is the prayer: Lord, we ask and pray that you stop the manipulation of Generex stock price.

    (1)
  30. hylander

    I know you are using 4.00, but I thought 2.00 and 3.00 are also possible.

  31. AlbertD

    Joe chose 400 million shares for a reason, even if he wasn't going to tip his hand entirely to why.

  32. Buildit

    On the NGIO listing topic, I've been mulling over the valuation/# of shares issue that's been

    (1)
  33. GMIN

    At least a blurb on their website . https://dawsonjames.com/transactions/

  34. pacsurg21

    https://www.nytimes.com/2020/10/15/business/vaxart-covid-coronavirus-vaccine.html For the issues

    (1)
  35. Buildit

    Maybe that progress is why my NGIO shares came over to my new Schwab account, but Victorys did

  36. Beasley

    I did the same thing https://www.nasdaq.com/market-activity/stocks/ngio As for Kiromic...there

    (1)
  37. Pokey123

    I hope AltuCell doesnt go the way of Kiromic.

  38. Pokey123

    Just an FYI, while adding KRBP to my biotech watch list I plugged in NGIO for laughs and guess

    (1)
  39. Cody760

    Now there was a missed opportunity

    (1)
  40. docj

    Sounds like we lost a big fish missing out on Kiromic Bio. Adding to my watchlist. Kiromic

    (1)
  41. hylander

    lets hope we hear something good today to end the week. It was looking good for a

  42. Pokey123

    Kiromic Biopharma has a form effect today. Looks like they are going to IPO.

  43. docj

    Amazing GILD was able to get EUA based on the limited success they had previously. Looks like

  44. Beasley

    Remdesivir

  45. Prometeus

    if 1 year ago you had asked me the same question (we were just over 2 $), I would have answered you

    (3)
  46. Vrsi

    Where do you all see us in a year (pps)? This should lighten the mood on the board a bit.... I hope

  47. Victory

    I added to my position yesterday and today. Now Ill wait and see where we go from

  48. GMIN

    WHO Covid vaccine list OCT 15

  49. GMIN

    Overall Management has failed to deliver. Are we in a better place thanks to Covid .....maybe. Lets

    (1)
  50. Cody760

    You have to give Joe credit: he used to be a little sloppy...or perhaps overly enthusiastic...when

    (4)

Top 10 Most Recent News Articles

More News Articles

Top 5 Most Recently Viewed Articles

Wesco International Earns Strong Results in Q3 Call Announcement

Updated Category News Views 227

Wesco International Announces Earnings Call for Third Quarter 2025 Pittsburgh – Wesco International (NYSE: WCC) is set to hold its earnings conference call discussing the achievements and financial performance for the third quarter of 2025. The call is scheduled for Thursday, October 30, providing investors and analysts an opportunity to engage with the leadership of...

Continue Reading
CHAR Technologies Completes Successful Private Placement Funding

Updated Category News Views 77

CHAR Technologies Completes Successful Private Placement CHAR Technologies Ltd. is excited to announce the completion of a significant non-brokered private placement that showcases its commitment to advancing sustainable energy solutions. The Company has issued 16,359,451 units, collectively raising gross proceeds of CDN$3,271,890. Details of the Offering Each unit...

Continue Reading
Codexis Showcases Innovations at Major Healthcare Conference

Updated Category News Views 100

Codexis' Upcoming Participation at a Healthcare Conference Codexis, Inc. (NASDAQ: CDXS), renowned for its state-of-the-art enzymatic solutions for manufacturing complex therapeutics, has exciting news for investors and stakeholders. The Company will attend the Cantor Global Healthcare Conference scheduled for early September, where it will showcase its innovative...

Continue Reading
Exploring the Latest Trends in RV, MHP, and Hospitality Investments

Updated Category News Views 495

Insights into the 2025 RV & MHP and Hospitality Investment Reports Leisure Investment Properties Group (LIPG) has recently unveiled its annual 2025 RV & MHP Investment Report along with the 2025 Hospitality Investment Report. These reports delve deep into two of the most dynamic sectors in real estate, providing critical insights and actionable data to assist investors in...

Continue Reading
Strategic Acquisition of Payfare Inc. by Fiserv Inc. in 2025

Updated Category News Views 434

Payfare Inc. Enters Acquisition Agreement with Fiserv Payfare Inc. (TSX: PAY), a prominent name known for its innovative Earned Wage Access (EWA) solutions, is excited to reveal its latest strategic move. The company has reached a definitive arrangement agreement with an affiliate of Fiserv, Inc. (NYSE: FI), a leader in payments and financial services technology. This...

Continue Reading